Innovative Medical (China) Buy Hold or Sell Recommendation
| 002173 Stock | 8.71 0.02 0.23% |
Assuming the 90 days trading horizon and your typical level of risk aversion, our recommendation regarding Innovative Medical Management is 'Strong Sell'. Macroaxis provides Innovative Medical buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding 002173 positions.
Check out Innovative Medical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Innovative and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Innovative Medical Management. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Innovative |
Execute Innovative Medical Buy or Sell Advice
The Innovative recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Innovative Medical Management. Macroaxis does not own or have any residual interests in Innovative Medical Management or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Innovative Medical's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Good | Details | |
Volatility | Slightly risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Innovative Medical Trading Alerts and Improvement Suggestions
| Innovative Medical appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 805.59 M. Net Loss for the year was (34.29 M) with profit before overhead, payroll, taxes, and interest of 46.16 M. | |
| About 42.0% of the company shares are owned by insiders or employees | |
| Latest headline from news.google.com: ICU Medical to Present at UBS Global Healthcare Conference in November 2024 ICUI Stock News - StockTitan |
Innovative Medical Returns Distribution Density
The distribution of Innovative Medical's historical returns is an attempt to chart the uncertainty of Innovative Medical's future price movements. The chart of the probability distribution of Innovative Medical daily returns describes the distribution of returns around its average expected value. We use Innovative Medical Management price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Innovative Medical returns is essential to provide solid investment advice for Innovative Medical.
| Mean Return | 0.61 | Value At Risk | -6.37 | Potential Upside | 6.93 | Standard Deviation | 4.05 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Innovative Medical historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Innovative Medical Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Capital Expenditures | 160.5M | 108.4M | 110.7M | 123.2M | 96.2M | 84.7M | |
| Net Income | (1.1B) | (314.5M) | (105.2M) | (73.7M) | (34.3M) | (36.0M) | |
| Dividends Paid | 11.9M | 3.7M | 2.4M | 795.0K | 1.5M | 1.4M | |
| Change To Inventory | (4.8M) | 17.2M | (8.0M) | (6.7M) | 6.8M | 7.2M | |
| Investments | 586M | (541M) | 5M | 460.0M | (415.3M) | (394.6M) | |
| Change In Cash | 306.5M | (533.1M) | (120.4M) | 432.6M | (409.3M) | (388.8M) | |
| Net Borrowings | (265.8M) | (61.9M) | (30M) | 11M | 12.7M | 13.3M | |
| Depreciation | 104.4M | 111.8M | 117.5M | 110.3M | 106.7M | 101.5M | |
| Change To Netincome | 139.7M | 988.6M | 138.1M | (14.4M) | (16.6M) | (15.8M) | |
| End Period Cash Flow | 879.3M | 346.1M | 225.7M | 658.3M | 249.0M | 482.6M | |
| Free Cash Flow | (64.1M) | 23.3M | (67.4M) | (147.6M) | (85.2M) | (89.5M) | |
| Other Non Cash Items | 27.0M | 14.4M | 9.5M | 12.8M | 10.0M | 16.6M |
Innovative Medical Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Innovative Medical or Health Care Providers & Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Innovative Medical's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Innovative stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.59 | |
β | Beta against Dow Jones | 0.12 | |
σ | Overall volatility | 4.28 | |
Ir | Information ratio | 0.12 |
Innovative Medical Volatility Alert
Innovative Medical Management shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Innovative Medical's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Innovative Medical's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Innovative Medical Fundamentals Vs Peers
Comparing Innovative Medical's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Innovative Medical's direct or indirect competition across all of the common fundamentals between Innovative Medical and the related equities. This way, we can detect undervalued stocks with similar characteristics as Innovative Medical or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Innovative Medical's fundamental indicators could also be used in its relative valuation, which is a method of valuing Innovative Medical by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Innovative Medical to competition |
| Fundamentals | Innovative Medical | Peer Average |
| Return On Equity | -0.0256 | -0.31 |
| Return On Asset | -0.0147 | -0.14 |
| Profit Margin | (0.06) % | (1.27) % |
| Operating Margin | (0.08) % | (5.51) % |
| Current Valuation | 3.36 B | 16.62 B |
| Shares Outstanding | 441.28 M | 571.82 M |
| Shares Owned By Insiders | 42.32 % | 10.09 % |
| Shares Owned By Institutions | 1.64 % | 39.21 % |
| Price To Book | 2.09 X | 9.51 X |
| Price To Sales | 4.86 X | 11.42 X |
| Revenue | 805.59 M | 9.43 B |
| Gross Profit | 46.16 M | 27.38 B |
| EBITDA | 33.94 M | 3.9 B |
| Net Income | (34.29 M) | 570.98 M |
| Total Debt | 30.17 M | 5.32 B |
| Book Value Per Share | 4.17 X | 1.93 K |
| Cash Flow From Operations | 11.03 M | 971.22 M |
| Earnings Per Share | (0.11) X | 3.12 X |
| Beta | 0.64 | -0.15 |
| Market Capitalization | 3.93 B | 19.03 B |
| Total Asset | 2.28 B | 29.47 B |
| Retained Earnings | (1.3 B) | 9.33 B |
| Working Capital | 407.63 M | 1.48 B |
| Net Asset | 2.28 B |
Innovative Medical Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Innovative . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 1.5 M | |||
| Daily Balance Of Power | (0.06) | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 8.79 | |||
| Day Typical Price | 8.76 | |||
| Price Action Indicator | (0.09) | |||
| Period Momentum Indicator | (0.02) |
About Innovative Medical Buy or Sell Advice
When is the right time to buy or sell Innovative Medical Management? Buying financial instruments such as Innovative Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Innovative Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Gold ETFs Thematic Idea Now
Gold ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Gold ETFs theme has 19 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Gold ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Innovative Stock
Innovative Medical financial ratios help investors to determine whether Innovative Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Innovative with respect to the benefits of owning Innovative Medical security.